Fleet Bioprocessing Ltd. has announced that it will be attending the European Bioanalytical Forum 11th Open Symposium on 21st – 23rd November 2018.
The EBF was founded in 2006 with the goal of bringing companies together to implement a platform for discussions of science, day-to-day procedures, business tools, technologies and regulatory issues.
Fleet Bioprocessing Ltd. offer unrivalled expertise in the development, validation and manufacture of bioconjugates. They also possess industry-leading expertise in all aspects of immunoassay design, development and validation and are a Certified Assay Transfer and Development Partner for the Gyrolab high-throughput immunoassay platform.